Law & Policy

·

Study

Most U.S. Psychiatrists Now Support Medical Psychedelics

Most U.S. Psychiatrists Now Support Medical Psychedelics

Psilocybin mushrooms

What they found

A 2022–23 survey found 72% of U.S. psychiatrists favor medical legalization of psychedelics and 81% see promise.

A 2022–23 survey found 72% of U.S. psychiatrists favor medical legalization of psychedelics and 81% see promise.

The number

favor medical legalization (72%)

How solid is it?

Early human

Early human

Human – observational/survey

Human – observational/survey

Evidence ladder: Lab dish → Animal → Early human → Strong human. Reviews summarize earlier research.

At a glance

Latin name

Compound

psilocybin

psilocybin

Sample size

U.S. psychiatrists

U.S. psychiatrists

Published in

Psychedelic Medicine

Psychedelic Medicine

Covered in Shroom Scan

Section

PSILOCYBIN & LEGISLATION

PSILOCYBIN & LEGISLATION

As it ran in Shroom Scan

Psychiatrists & Psychedelics

Psychiatrists & Psychedelics

A 2022–23 survey of U.S. psychiatrists found rising support for psychedelic-assisted therapy. Compared to 2016, more psychiatrists favor medical legalization (72%), see promise in treating psychiatric disorders (81%), and plan to incorporate psychedelics into practice (50%).

A 2022–23 survey of U.S. psychiatrists found rising support for psychedelic-assisted therapy. Compared to 2016, more psychiatrists favor medical legalization (72%), see promise in treating psychiatric disorders (81%), and plan to incorporate psychedelics into practice (50%).

Flu Defense, Joint Health, and Psilocybin’s Metabolic Edge

Read the original study ↗

Get Shroom Scan

Next study

Psychedelics Boost Brain Plasticity and New Neuron Growth ›

Shroom Scan · Every Friday

Get Studies Like This, Translated, Every Week

Ten new studies a week, each boiled down to what it found and why it matters to you. Free, and one click to leave.

See what's inside →